Clinical Trial

Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule

Study acronym: NV-SCC
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about survival and prognostic factors in patients who underwent surgical treatment for primary squamous cell carcinoma of the nasal vestibule. The main questions it aims to answer are: * what is the prognosis of patients affected by squamous cell carcinoma of the nasal vestibule? * are there any specific factors that could influence prognosis? * is it possible to elaborate a new staging system, able to overcome the limitations of the currently used ones? Data about patients, tumour and type of surgery performed will be collected. Participants will be followed-up for a minimum 6 months period after surgery.
Trial Details
NCT Number NCT05693116
Lead Sponsor Istituto Clinico Humanitas
Conditions Nasal Vestibule Carcinoma, Rhinectomy, Nasal Vestibule, Squamous Cell Carcinoma
Enrollment 300 participants
Start Date 2022-12-01
Primary Completion 2027-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2023-01-20